Sun Pharma Agrees to Acquire Organon in $75 Billion Cash Deal
Sun Pharma has signed a definitive agreement to acquire Organon for $75 billion in cash. The deal sets the acquisition price at $00 per share and is expected to close in early 2027. It remains subject to regulatory and stockholder approvals.
thehindubusinessline.comhas agreed to acquire Organon in a cash transaction valued at $75 billion, according to a report from @FirstSquawk. The acquisition price is set at $00 per share in cash, the report stated.
The transaction is expected to close in early 2027, @FirstSquawk reported. It remains pending regulatory and stockholder approvals, according to the report.
The deal involves Sun Pharma, an India-based pharmaceutical company, acquiring Organon, a U.S.-based firm focused on women's health and biosimilars. This acquisition could combine resources in the pharmaceutical sector, though specific details on strategic benefits were not provided in the report.
Stakeholders affected include Organon stockholders, who would receive the cash payment upon approval. Next steps involve obtaining necessary approvals from regulators and stockholders before the expected closure date.
Key Facts
Story Timeline
2 events- 2026-04-27
Sun Pharma signed a definitive agreement to acquire Organon for $75 billion in cash.
1 source@FirstSquawk - Early 2027
The transaction is expected to close, pending approvals.
1 source@FirstSquawk
Potential Impact
- 01
Organon stockholders could receive cash payments upon deal approval.
- 02
The acquisition may lead to combined operations in the pharmaceutical sector.
- 03
Regulatory reviews could delay the expected early 2027 closure.
- 04
Sun Pharma's portfolio could expand through Organon's assets.
Transparency Panel
Related Stories
deccanchronicle.comHantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Risk
A hantavirus outbreak on the MV Hondius cruise ship has killed three passengers and sickened seven others, prompting an international response coordinated by the World Health Organization. The ship, carrying 147 people from 23 nationalities, is set to sail to Spain's Canary Islan…
techjuice.pkImperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Ireland
A new report from Imperial College London highlights growing wildfire threats in Northern Ireland due to more favorable conditions, especially in spring. Researchers note increased drought and fire-prone weather, exacerbated by climate change. The findings point to longer fire se…
The U.S. Food and Drug Administration / Wikimedia (Public domain)FDA Commissioner Defends Drug Rejection Decisions
The FDA commissioner defended recent drug rejections in a CNBC interview, citing adherence to scientific reviews amid reports of agency turmoil. Criticism includes a high-profile denial of a melanoma treatment from Replimune and pressure from President Trump over vape approvals.…